Geoffrey Frederick O'Brien as Trustee for the Hydration Pharmaceuticals Trust – Trademark Portfolio
Entity Type: 01
Geoffrey Frederick O'Brien as Trustee for the Hydration Pharmaceuticals Trust holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 32 (Light Beverages) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. The owner is based in Melbourne, Victoria.
Level 5
114 William Street
Melbourne, Victoria 3000 , AU
Showing of trademarks Trademarks
Trademark Classifications
Geoffrey Frederick O'Brien as Trustee for the Hydration Pharmaceuticals Trust's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Geoffrey Frederick O'Brien as Trustee for the Hydration Pharmaceuticals Trust have?
Geoffrey Frederick O'Brien as Trustee for the Hydration Pharmaceuticals Trust has 3 U.S. trademarks filed with the USPTO.
What trademark classes does Geoffrey Frederick O'Brien as Trustee for the Hydration Pharmaceuticals Trust file in?
Geoffrey Frederick O'Brien as Trustee for the Hydration Pharmaceuticals Trust files trademarks across 2 Nice Classification classes. The most active classes are Class 32 (Light Beverages), Class 5 (Pharmaceuticals). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.
What is Geoffrey Frederick O'Brien as Trustee for the Hydration Pharmaceuticals Trust's trademark registration success rate?
Geoffrey Frederick O'Brien as Trustee for the Hydration Pharmaceuticals Trust has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.